An evaluation of neglected tumors: Giant basal cell carcinomas

Aim: Giant basal cell carcinomas (GBCCs) which constitute approximately 1% of basal cell carcinoma are aggressive tumorscharacterized by deep tissue invasion, high risk of metastasis, and poor prognosis. We aimed to analyze demographics, treatment,and outcome of patients with GBCCs in this study.Material and Methods: Between 2017 and 2020, nine patients applied to Department of Plastic and Reconstructive Surgery andunderwent surgical treatment for GBCC were included in the study. Age, sex, localization, tumor size, treatment and comorbiddiseases of the patients were reviewed retrospectively.Results: Six patiens were male and three patients were female. The mean age was 68.6 ±3.8 years, ranging from 62 to 78 years. Thetumors were located on cheek (n=4), frontotemporal region (n=2), cheek nose lower eyelid junction (n=1), scalp(n=1) and dorsumof the hand (n=1). The largest of the lesions was 8x10 cm and the smallest was 4x6 cm.The defect sizes following tumor removalranged from 24 to 80cm2 with an average of 43,6 cm2. Nodular GBCC was the most common histological subtype (n=6), followed bysuperficial (n=2) and morpheaform (n=1). Two patients were skin grafted after excision of GBCC whereas cheek rotation flaps (n=2),cervicofacial flaps (n=3) and pedicled forehead flaps (n=2) were utilized for reconstruction.Conclusion: Since health insurance covers oncologic surgery and there is an extreme ease to reach a health professional in ourcountry, the most common reason to still encounter GBCC seems like negligence. GBCCs are rare, but they need proper interventionswhen detected. Aggressive surgery should not be avoided for better outcomes.

PDF

___

1. Arslan H, Güzel MZ, Çınar C. Treatment of giant basal cell carcinomas of the head and neck with aggressive resection and complex reconstruction. J Craniofac Surg 2012;23:1634-7.
2. Walling H, Fosko S, Geraminejad P, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and manage¬ment. Cancer Metastasis Rev 2004;23:389- 402.
3. Zoccali G, Pajand R, Papa P, et al. Giant basal cell carcinoma of the skin: literature review and personal experience. J Eur Acad Dermatol Venereol 2012;26:942–52.
4. Manstein CH, Manstein ME, Beidas OE. Giant basal cell carcinoma: 11-year follow-up and seven new cases. Plast Reconstr Surg 2000;106:653–6.
5. Hernández FJ, Centeno MC, Pérez MB, et al. Giant Basal Cell Carcinoma: A 12-Year Follow-up Case Report. Am J Dermatopathol 2016;38:52–5.
6. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 2009;29:2655–63.
7. Gualdi G, Monari P, Calzavara-Pinton P, et al. When basal cell carcinomas became giant: an Italian multicenter study. Int J Dermatol 2020;59:377–82.
8. Bellahammou K, Lakhdissi A, Akkar O, et al. Metastatic giant basal cell carcinoma: a case report. Pan African Med J 2016;24:157.
9. Wollina U, Bayyoud Y, Krönert C, et al. Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center. J Cutan Aesthet Surg 2012;5:12–9.
10. Erdem H, Kadioglu N, Uzunlar AK, et al. An aggressive basal cell carcinoma with multiple focuses and distant lung metastasis: case report. Cumhuriyet Med J 2012;34:510–5.
11. Lorenzo SD, Zabbia G, Corradino B, et al. A Rare Case of Giant Basal Cell Carcinoma of the Abdominal Wall: Excision and Immediate Reconstruction with a Pedicled Deep Inferior Epigastric Artery Perforator (DIEP) Flap. Am J Case Rep 2017;18:1284-8.
12. Wollina U. Massive scalp myiasis with bleeding in a patient with multiple malignancies. Int Wound J 2010;7:297-9.
13. Varga E, Korom I, Raskó Z, et al. Neglected basal cell carcinomas in the 21st century. J Skin Cancer 2011:4. Article ID 392151.
14. Aldhaban S, Sidham Marc, Eshki M. Giant basal cell carcinoma with regional lymph node and distant lung metastasis. Eur J Dermatol 2011;21:972–5.
15. Heo YS, Yoon JH, Choi JE, et al. A case of superficial giant basal cell carcinoma with satellite lesions on scalp. Ann Dermatol 2011;23:111–5.
16. Copcu E, Aktas A. Simultaneous two organ metastases of the giant basal cell carcinoma of the skin. Int Semin Surg Oncol 2005;2:1.
17. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol 1999;141:415-23.
18. 18. Mott SE, Hunter WJ, Silva E, Huerter CJ. Approach to management of giant basal cell carcinomas. Cutis 2017;99:356-62.
19. Sanmartín V, Aguayo R, Baradad M, et al. Tratamiento neoadyuvante con acitretino oral e imiquimod tópico en el carcinoma basocelular gigante [in Spanish]. Actas Dermosifilogr 2012;103:149–52.
20. Rudin CM. Vismodegib. Clin Cancer Res. 2012;18:3218–22.
21. 21. Sekulic A, Migden MR, Oro AE et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366:2171–9.
22. Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453–9.
23. Zagrodnik B, Kempf W, Seifert B. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003;98:2708–14.
24. Petit JY, Avril MF, Margulis A. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000;105:2544–51.
25. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 2007;4:462-9.
26. Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 2007;109:1053–9.